National Health and Nutrition Examination Survey

2001-2002 Data Documentation, Codebook, and Frequencies

Vitamin D, Second Exam (VID_2_B)

Data File: VID_2_B.xpt

First Published: October 2008

Last Revised: NA

Component Description

The objectives of this component are:

to provide data for monitoring secular trends in measures of nutritional status in the U.S. population;
to evaluate the effect of people's habits and behaviors such as physical activity and the use of alcohol, tobacco, and dietary supplements on people's nutritional status; and
to evaluate the effect of changes in nutrition and public health policies including welfare reform legislation, food fortification policy, and child nutrition programs on the nutritional status of the U.S. population.

These data will be used to estimate deficiencies and toxicities of specific nutrients in the population and subgroups, to provide population reference data, and to estimate the contribution of diet, supplements, and other factors to serum levels of nutrients. Data will be used for research to further define nutrient requirements as well as optimal levels for disease prevention and health promotion.

Eligible Sample

Participants aged 16-69 years and older who do not meet any of the exclusion criteria are eligible.

Description of Laboratory Methodology

The Diasorin (formerly Incstar) 25-OH- Vitamin D assay consists of a two-step procedure. The first procedure involves an extraction of 25-OH-D and other hydroxylated metabolites from serum with acetonitrile. Following extraction, the treated sample is assayed by using an equilibrium RIA procedure. The RIA method is based on an antibody with specificity to 25-OH-D. The sample, antibody, and tracer are incubated for 90 min at 20-25 °C. Phase separation is accomplished after a 20-minute incubation at 20-25 °C with a second antibody-precipitating complex. A NSB buffer is added after this incubation and prior to centrifugation to aid in reducing non-specific binding. More detailed information about the Diasorin RIA method can be found on the NHANES Web site in the Laboratory Procedures Manuals.

Data Processing and Editing

Serum specimens are processed, stored, and shipped to the Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention for analysis.

Detailed specimen collection and processing instructions are discussed in the NHANES Laboratory/Medical Technologists Procedures Manual (LPM). Vials are stored under appropriate frozen (–20°C) conditions until they are shipped to National Center for Environmental Health for testing.

All data are publicly available.

Detailed instructions on specimen collection and processing can be found at the NHANES web page.

Laboratory Quality Assurance and Monitoring

The NHANES quality assurance and quality control (QA/QC) protocols meet the 1988 Clinical Laboratory Improvement Act mandates. Detailed QA/QC instructions are discussed in the NHANES Laboratory/Medical Technologists Procedures Manual (LPM). Read the LABDOC file for detailed QA/QC protocols.

A detailed description of the quality assurance and quality control procedures can be found on the NHANES website.

Analytic Notes

The second day exam data was a convenience sample and thus did not have sample weights. The analysis of NHANES 2001–2002 laboratory data must be conducted with the key survey design and basic demographic variables. The NHANES 2001–2002 Household Questionnaire Data Files contain demographic data, health indicators, and other related information collected during household interviews. The Household Questionnaire Data Files also contain all survey design variables required to analyze these data. The Phlebotomy Examination file includes auxiliary information on duration of fasting, the time of day of the venipuncture, and the conditions precluding venipuncture. The Household Questionnaire and Phlebotomy Exam files may be linked to the laboratory data file using the unique survey participant identifier SEQN.

Please refer to the Analytic Guidelines for further details.

References

Adams JS, Clemens TL, Parrish JA, Holick MF. Vitamin D synthesis and metabolism after ultraviolet radiation of normal and vitamin d-deficient subjects. N Eng J Med 1982;306(12):722.
Beadle PC, Burton JL, Leach JF. Correction of seasonal variation of 25-hydroxycalciferol with U.V. radiation dose. Br J Dermatol 1980;102:289.
Chesney RW. Current Clinical applications of vitamin D metabolite research. Clin Orthop Rel Res 1981;161:285.
Clemens TE. Vitamin D: Recent advances in basic research and clinical assay methodology. J Clin Immunoass 1986;9(4):183.
Decontamination of laboratory sink drains to remove azide salts. In: the manual guide-safety management, No. CDC-22. Atlanta: Centers for Disease Control, 1976.
DeLuca HF, Schnoes HK. Metabolism and mechanism of action of vitamin D. Annu Rev Biochem 1976;45:631.
Hollis BW, Kamerud JQ, Selvaag SR, Lorenz JD, Napoli JL. Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer. Clin Chem 1993;39(3):529-33.
Hollis BW, Pittard WB. Evaluation of the total fetomaternal vitamin D relationships at term: evidence for racial differences. J Clin Endocrin Metab 1984;59(4):652.
Hollis BW, Pittard WB. Relative concentrations of 25-hydroxyvitamin D2/D3 and 1,25-dihydroxyvitamin D2/D3 in maternal plasma at delivery. Nutr Res 1984;4:27.
Instruction Manual, Diasorin (formerly Incstar) 25-Hydroxyvitamin D 125I RIA kit. Stillwater, (MN): Diasorin (formerly Incstar) Corporation, 1994.
Jacob AI, Sallman A, Santiz S, Hollis BW. Defective photoproduction of cholecalciferol in normal and uremic humans. J Nutr 1984;114:1313.
Kruger DW, Lee J, Raines A, Lyne ED. Vitamin D metabolism and skeletal disease in pediatric populations. J Clin Immunoass 1986;9(4):200.
Lore F, DiCairano, Signorini AM, Caniggia A. Serum levels of 25-hydroxyvitamin D in postmenopausal osteoporosis. Calcif Tissue Int 1981;33:467.
Parfitt AM, Gallagher JC, Heaney RP, et al. Vitamin D and bone health in the elderly. Am J Clin Nutr 1982;36:101.
Preece MA, Tomlenson S, Ribot CA. Studies of vitamin D deficiency in man. Q J Med 1975;45:575.
Zerwehk JE, Sakhee K, Glass K, Pak C. Long term 25-hydroxyvitamin D3 therapy in postmenopausal osteoporosis: demonstration of responsive and non-responsive subgroups. J Clin Endocrinol Metab 1983;56(2):410.

Codebook and Frequencies

SEQN - Respondent sequence number

Variable Name:: SEQN
SAS Label:: Respondent sequence number
English Text:: Respondent sequence number.
Target:: Both males and females 16 YEARS - 69 YEARS

LB2DAY - Days between first and second exams

Variable Name:: LB2DAY
SAS Label:: Days between first and second exams
English Text:: Days between first and second exams
Target:: Both males and females 16 YEARS - 69 YEARS

Code or Value	Value Description	Count	Cumulative	Skip to Item
3 to 45	Range of Values	469	469
.	Missing	82	551

LB2VID - Vitamin D (ng/mL)

Variable Name:: LB2VID
SAS Label:: Vitamin D (ng/mL)
English Text:: Vitamin D (ng/mL)
Target:: Both males and females 16 YEARS - 69 YEARS

Code or Value	Value Description	Count	Cumulative	Skip to Item
3 to 61	Range of Values	469	469
.	Missing	82	551

Table of Contents